Literature DB >> 1861862

Constitutive overexpression of a 89 kDa heat shock protein gene in the HBL100 human mammary cell line converted to a tumorigenic phenotype by the EJ/T24 Harvey-ras oncogene.

J Lebeau1, C Le Chalony, M T Prosperi, G Goubin.   

Abstract

The non tumorigenic human mammary cell line HBL100 has been transformed by the EJ/T24 human bladder carcinoma Harvey(Ha)-ras oncogene. Six cell lines were established from transformed colonies. They all expressed a high level of the ras oncogene and were tumorigenic in athymic nude mice. During an in vivo passage in animals, tumour cells presenting a growth advantage were selected, and some of the tumours revealed an amplification of the transfected ras sequences. Using this model of human cell transformation, we have isolated a cDNA clone corresponding to a heat shock protein gene (hsp89 alpha). This gene, normally transcribed at a higher rate in response to serum stimulation, was found to be constitutively overexpressed in ras-transformed HBL100 cells. In contrast, a closely related hsp gene (hsp89 beta), remained sensitive to serum stimulation, in both untransformed and ras-transformed HBL100 cells. Thus, the regulation of the expression of the hsp89 genes, upon serum stimulation, involves ras-dependent and ras-independent pathways. Constitutive overexpression of the murine homolog of the hsp89 alpha was observed in NIH3T3 cells transformed by the three ras oncogenes, but not with some other oncogenes. Therefore, alteration of the hsp89 alpha gene expression is not a general characteristic of transformed cells, but seems to be linked to ras transformation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1861862

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

1.  Genetic prognostic index influences patient outcome for node-positive breast cancer.

Authors:  Shin-Ichi Asaka; Takashi Fujimoto; Junko Akaishi; Kenji Ogawa; Masamitsu Onda
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

2.  Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice.

Authors:  G Schwab; C Chavany; I Duroux; G Goubin; J Lebeau; C Hélène; T Saison-Behmoaras
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

3.  Differential expression of novH and CTGF in human glioma cell lines.

Authors:  L W Xin; C Martinerie; W Zumkeller; M Westphal; B Perbal
Journal:  Clin Mol Pathol       Date:  1996-04

Review 4.  Geldanamycin as a potential anti-cancer agent: its molecular target and biochemical activity.

Authors:  L Neckers; T W Schulte; E Mimnaugh
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

5.  Hybridization specificity, enzymatic activity and biological (Ha-ras) activity of oligonucleotides containing 2,4-dideoxy-beta-D-erythro-hexopyranosyl nucleosides.

Authors:  K Augustyns; G Godard; C Hendrix; A Van Aerschot; J Rozenski; T Saison-Behmoaras; P Herdewijn
Journal:  Nucleic Acids Res       Date:  1993-10-11       Impact factor: 16.971

6.  Rational design of point mutation-selective antisense DNA targeted to codon 12 of Ha-ras mRNA in human cells.

Authors:  I Duroux; G Godard; M Boidot-Forget; G Schwab; C Hélène; T Saison-Behmoaras
Journal:  Nucleic Acids Res       Date:  1995-09-11       Impact factor: 16.971

7.  Structural determination of three different series of compounds as Hsp90 inhibitors using 3D-QSAR modeling, molecular docking and molecular dynamics methods.

Authors:  Jianling Liu; Fangfang Wang; Zhi Ma; Xia Wang; Yonghua Wang
Journal:  Int J Mol Sci       Date:  2011-01-30       Impact factor: 5.923

8.  Cytogenetic characterization and H-ras associated transformation of immortalized human mammary epithelial cells.

Authors:  Krishna Rao; Ozge Alper; Kent E Opheim; George Bonnet; Kristine Wolfe; Eileen Bryant; Siobhan O'Hara Larivee; Peggy Porter; James K McDougall
Journal:  Cancer Cell Int       Date:  2006-05-26       Impact factor: 5.722

9.  HSP90 Inhibitors, Geldanamycin and Radicicol, Enhance Fisetin-Induced Cytotoxicity via Induction of Apoptosis in Human Colonic Cancer Cells.

Authors:  Ming-Shun Wu; Gi-Shih Lien; Shing-Chuan Shen; Liang-Yo Yang; Yen-Chou Chen
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-11       Impact factor: 2.629

10.  The suppression of fibroblast growth factor 2/fibroblast growth factor 4-dependent tumour angiogenesis and growth by the anti-growth factor activity of dextran derivative (CMDB7).

Authors:  R Bagheri-Yarmand; Y Kourbali; C Mabilat; J F Morère; A Martin; H Lu; C Soria; J Jozefonvicz; M Crépin
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.